GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 75 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,000 | +41.2% | 18,419 | +71.2% | 0.00% | – |
| Q1 2022 | $17,000 | -26.1% | 10,760 | -4.7% | 0.00% | – |
| Q4 2021 | $23,000 | -59.6% | 11,291 | -23.3% | 0.00% | – |
| Q3 2021 | $57,000 | -1.7% | 14,717 | -19.0% | 0.00% | – |
| Q2 2021 | $58,000 | +28.9% | 18,175 | -12.7% | 0.00% | – |
| Q1 2021 | $45,000 | -13.5% | 20,812 | -10.1% | 0.00% | – |
| Q4 2020 | $52,000 | -5.5% | 23,161 | +12.1% | 0.00% | – |
| Q3 2020 | $55,000 | -14.1% | 20,654 | -0.7% | 0.00% | – |
| Q2 2020 | $64,000 | +93.9% | 20,794 | +24.7% | 0.00% | – |
| Q1 2020 | $33,000 | -64.1% | 16,675 | -48.0% | 0.00% | – |
| Q4 2019 | $92,000 | -39.5% | 32,076 | -22.9% | 0.00% | – |
| Q3 2019 | $152,000 | -82.9% | 41,592 | -76.2% | 0.00% | – |
| Q1 2019 | $891,000 | +1756.2% | 174,391 | +1139.6% | 0.00% | – |
| Q4 2018 | $48,000 | -50.0% | 14,068 | -11.8% | 0.00% | – |
| Q3 2018 | $96,000 | +128.6% | 15,956 | +27.4% | 0.00% | – |
| Q4 2017 | $42,000 | +40.0% | 12,528 | -10.8% | 0.00% | – |
| Q3 2017 | $30,000 | -28.6% | 14,049 | -17.9% | 0.00% | – |
| Q2 2017 | $42,000 | +5.0% | 17,104 | -1.5% | 0.00% | – |
| Q1 2017 | $40,000 | +166.7% | 17,371 | +13.2% | 0.00% | – |
| Q4 2016 | $15,000 | -16.7% | 15,345 | -6.3% | 0.00% | – |
| Q3 2016 | $18,000 | -25.0% | 16,371 | -0.4% | 0.00% | – |
| Q2 2016 | $24,000 | -96.8% | 16,438 | -96.8% | 0.00% | – |
| Q1 2016 | $744,000 | -13.3% | 520,381 | -0.5% | 0.00% | – |
| Q4 2015 | $858,000 | +725.0% | 523,245 | +1069.7% | 0.00% | – |
| Q3 2015 | $104,000 | -21.8% | 44,732 | -8.4% | 0.00% | – |
| Q2 2015 | $133,000 | +62.2% | 48,812 | +100.6% | 0.00% | – |
| Q1 2015 | $82,000 | -4.7% | 24,336 | -1.6% | 0.00% | – |
| Q4 2014 | $86,000 | -34.8% | 24,740 | -5.4% | 0.00% | – |
| Q3 2014 | $132,000 | -86.2% | 26,141 | -62.3% | 0.00% | – |
| Q2 2014 | $958,000 | +17.7% | 69,410 | +30.6% | 0.00% | – |
| Q1 2014 | $814,000 | – | 53,144 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |